LONGECITY

this is a very interesting new article i have read today and i will share with the rest of you here; http://www.medicalne...ases/309503.php

 

so basically it seems to work and we are in the progress of advancing in this aspect quite sooner than we thought. now, i dont even wanna bother learning the price of doing this.....

She wasn't made younger.  The telomeres in her blood cells were lengthened.  What about the telomeres in all the other tissues of her body? Her organs? Her skin?  And how is the myostatin gene therapy going for her? 

There is the  same Article on this here:

http://www.neuroscie...nst-human-aging

 

I think the negative reactions to the article is because they were not accurate in their description of the findings.

 

How ever, I think this is a great leap in the direction we want to go.

 

 

She wasn't made younger.  The telomeres in her blood cells were lengthened.  What about the telomeres in all the other tissues of her body? Her organs? Her skin?  And how is the myostatin gene therapy going for her? 

 

relax buddy that is actually a move in the right direction there is a lot of potential with this and you are so skeptical as if that didnt do anything worth it. of course as being one of the first experimental therapies she wont magically just become younger lol silly you would have such high hopes before you click the url

If you read my other posts you would know I think the role of telomeres in aging may be very large. But I don't see anything coming from Bioviva except cheerleading and tabloid type interviews. So she took a pre and post blood test to measure the telomeres in her blood? Thats it? Thats hard hitting real science? What's happening with the telomeres in her other body tissues? Did they even look before the test? No. Are they looking now? Not from what I can see from her fluff interviews. Aging research deserves more and better.

AFAIK, Liz Parrish has been or is selling stock in her company, BioViva.  Without a really strong, independent analysis, I'd be wary about what they are selectively disclosing.

 

This isn't just about telomeres or gene therapy, it's about money and a company's business plan.

Edited by prophets, 27 April 2016 - 02:16 AM.